LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Pfizer

Затворен

СекторЗдравеопазване

25.07 -2.79

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

25.06

Максимум

25.23

Ключови измерители

By Trading Economics

Приходи

623M

3.6B

Продажби

2B

17B

P/E

Средно за сектора

14.18

105.69

EPS

0.87

Дивидентна доходност

6.96

Марж на печалбата

21.322

Служители

81,000

EBITDA

325M

5.6B

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+12.76% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

6.96%

2.37%

Следваща дата на дивидент

1.12.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-1.5B

139B

Предишно отваряне

27.86

Предишно затваряне

25.07

Настроения в новините

By Acuity

39%

61%

142 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Pfizer Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

13.11.2025 г., 17:39 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Completes Acquisition of Metsera

10.11.2025 г., 13:08 ч. UTC

Значими двигатели на пазара
Придобивния, сливания и поглъщания

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

10.11.2025 г., 09:41 ч. UTC

Придобивния, сливания и поглъщания

Novo Nordisk Shares Rise After Withdrawal of Metsera Takeover Battle

14.11.2025 г., 12:22 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Pharma Sector Becoming Bidding Battlefield -- Market Talk

13.11.2025 г., 16:26 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Completes Acquisition Of Metsera >PFE

10.11.2025 г., 16:35 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Pfizer CEO Confident Metsera Therapies Will Get Approval -- Market Talk

10.11.2025 г., 16:26 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Pfizer CEO: Metsera Has Exciting Weight-Loss Portfolio -- Market Talk

10.11.2025 г., 15:36 ч. UTC

Придобивния, сливания и поглъщания

What's Next for Novo Nordisk? -- WSJ

10.11.2025 г., 14:05 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Pfizer Will See Big Benefits from Metsera Acquisition -- Market Talk

10.11.2025 г., 12:33 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10.11.2025 г., 12:32 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10.11.2025 г., 10:45 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, CoreWeave, and More -- Barrons.com

10.11.2025 г., 10:34 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, CoreWeave, and More -- Barrons.com

10.11.2025 г., 10:32 ч. UTC

Горещи акции

Stocks to Watch Monday: Metsera, Novo Nordisk, Nvidia, Tyson Foods -- WSJ

10.11.2025 г., 09:26 ч. UTC

Придобивния, сливания и поглъщания

Novo Nordisk Shares Rise After Withdrawal From Metsera Takeover Battle

8.11.2025 г., 13:10 ч. UTC

Придобивния, сливания и поглъщания

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8.11.2025 г., 03:50 ч. UTC

Придобивния, сливания и поглъщания

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8.11.2025 г., 03:41 ч. UTC

Придобивния, сливания и поглъщания

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8.11.2025 г., 03:07 ч. UTC

Придобивния, сливания и поглъщания

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7.11.2025 г., 13:26 ч. UTC

Придобивния, сливания и поглъщания

Correction to This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. Article -- WSJ

7.11.2025 г., 10:30 ч. UTC

Придобивния, сливания и поглъщания

This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. -- WSJ

6.11.2025 г., 20:02 ч. UTC

Придобивния, сливания и поглъщания

Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. -- Barrons.com

6.11.2025 г., 16:16 ч. UTC

Печалби

Moderna's Quarter Wasn't As Bad as It Could Have Been. The Stock is Up -- Barrons.com

6.11.2025 г., 12:29 ч. UTC

Печалби

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6.11.2025 г., 12:15 ч. UTC

Печалби

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6.11.2025 г., 00:24 ч. UTC

Придобивния, сливания и поглъщания

Metsera: Pfizer Has Reiterated It Will Continue to Litigate >MTSR

6.11.2025 г., 00:24 ч. UTC

Придобивния, сливания и поглъщания

Metsera: Board of Directors Will Continue to Stand Firm on Behalf of Shareholders, Patients >MTSR

6.11.2025 г., 00:24 ч. UTC

Придобивния, сливания и поглъщания

Metsera: Gratified by Court Decision to Deny Pfizer's Request for Temporary Restraining Order to Block Board From Acting in Shareholders' Best Interests >MTSR

6.11.2025 г., 00:22 ч. UTC

Придобивния, сливания и поглъщания

Metsera Issues Statement in Response to Pfizer Litigation Ruling

5.11.2025 г., 22:44 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

Сравнение с други в отрасъла

Ценова промяна

Pfizer Прогноза

Ценова цел

By TipRanks

12.76% нагоре

12-месечна прогноза

Среден 29.08 USD  12.76%

Висок 34 USD

Нисък 24 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за Pfizer през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

15 ratings

4

Купи

10

Задържане

1

Продай

Техническа оценка

By Trading Central

22.855 / 23.85Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

142 / 374 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat